This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Jhm Biopharmaceutical (Hangzhou) Co., Ltd.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Yubao Shen - Innovator in Biopharmaceuticals
Introduction: Yubao Shen is an accomplished inventor based in Hangzhou, China. He is currently associated with JHM Biopharmaceutical (Hangzhou) Co., Ltd. Despite having no granted patents to his name, his contributions to the field of biopharmaceuticals are noteworthy. His work focuses on innovative methods and applications that have the potential to advance medical science.
Latest Patent Applications: Yubao Shen has been involved in several significant patent applications. One of his latest applications is for a recombinant botulinum neurotoxin of type A and its preparation method. This application details a BoNT/A mutant that includes a first peptide fragment and a second peptide fragment linked through an interchain disulfide bond. The method involves specific renaturation treatments to obtain the BoNT/A mutant. Another notable application is for a growth hormone fusion protein, which includes a double-stranded structure with a growth hormone linked to a constant region Fc segment. This innovation aims to prolong the in vivo half-life of the growth hormone while ensuring higher safety and stronger activity.
Conclusion: Yubao Shen's work in the biopharmaceutical sector showcases his innovative spirit and dedication to advancing medical technologies. His latest patent applications reflect his commitment to developing effective solutions in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile